tenofovir has been researched along with pradimicin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; Camarasa, MJ; Carrero, P; Doyagüez, EG; Leyssen, P; Madrona, A; Neyts, J; Paeshuyse, J; Peréz-Pérez, MJ; Quesada, E; Rivero-Buceta, E; San-Félix, A | 1 |
| Balzarini, J; Camarasa, MJ; Colomer, I; Doyagüez, EG; Liekens, S; Mathys, L; Noppen, S; Pérez-Pérez, MJ; Quesada, E; Rivero-Buceta, E; San-Félix, A | 1 |
2 other study(ies) available for tenofovir and pradimicin a
| Article | Year |
|---|---|
Linear and branched alkyl-esters and amides of gallic acid and other (mono-, di- and tri-) hydroxy benzoyl derivatives as promising anti-HCV inhibitors.
Topics: Alkylation; Amides; Antiviral Agents; Dose-Response Relationship, Drug; Esters; Gallic Acid; Hepacivirus; HIV; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2015 |
Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41.
Topics: Anti-HIV Agents; Binding Sites; Dendrimers; Dose-Response Relationship, Drug; HIV; HIV Envelope Protein gp120; HIV Envelope Protein gp41; Humans; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Receptors, HIV; Structure-Activity Relationship; Tryptophan; Tumor Cells, Cultured; Virus Internalization; Virus Replication | 2015 |